Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Cash & Equivalents (2016 - 2025)

HUTCHMED (China) (HCM) has disclosed Cash & Equivalents for 12 consecutive years, with $71.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 15.57% to $71.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $71.3 million, a 15.57% decrease, with the full-year FY2025 number at $71.3 million, down 15.57% from a year prior.
  • Cash & Equivalents was $71.3 million for Q4 2025 at HUTCHMED (China), down from $84.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $377.5 million in Q4 2021 to a low of $71.3 million in Q4 2025.
  • A 5-year average of $226.0 million and a median of $283.6 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 329.87% in 2021, then crashed 70.21% in 2024.
  • HUTCHMED (China)'s Cash & Equivalents stood at $377.5 million in 2021, then decreased by 17.02% to $313.3 million in 2022, then decreased by 9.48% to $283.6 million in 2023, then plummeted by 70.21% to $84.5 million in 2024, then decreased by 15.57% to $71.3 million in 2025.
  • Per Business Quant, the three most recent readings for HCM's Cash & Equivalents are $71.3 million (Q4 2025), $84.5 million (Q4 2024), and $283.6 million (Q4 2023).